Novo Nordisk A/S
Common Stock · USD · NYSE
Price
$45.66
Cap
—
Earnings
—
30d Trend
+10.2%
136% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 34×Macro 0.99 (−1%)=34
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Potential value play — but fundamentals need strengthening
BRAIN47'S ASSESSMENT
I rate Novo Nordisk A/S at 34/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+6.7%
3 MONTHS
-36.0%
12 MONTHS
-20.0%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Potential value play — but fundamentals need strengthening. Fundamentals (90) and Quality (48) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 136%. I classify this as a speculative position — elevated volatility at 136% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.